News
Pharma update: Cross border injunction imatinib granted against Teva
In his decision of 30 March 2016 in the matter Novartis AG v Teva Nederland B.V. et al., the Provisions Judge of the District Court in The Hague held that Novartis is entitled to a Paediatric Extension for Glivec® (imatinib), based on Supplementary Protection Certificate no. 300086. The Provisions Judge has provisionally prohibited Teva to
Read more ›
